First-in-Human Clinical Trial of STUP-001, an In Vivo Direct Cell Conversion Gene Therapy for AIS-A/B Chronic Spinal Cord Injury

NCT06922890 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Spinal Cord Injury
Chronic Spinal Cord Injury

Interventions

DRUG: STUP-001

Sponsor

Yonsei University

Collaborators

[object Object]